跳至主要内容
临床试验/NCT02580903
NCT02580903已完成不适用

Pulmonary Hypertension in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms; an Observational Prospective Study

Odense University Hospital1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
1
主要终点
Prevalence of pulmonary hypertension at initial presentation and first echo

研究概览

简要总结

This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis.

All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association.

All patients will be followed up for a total of five years to identify prognosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Myeloproliferative Neoplasms (PV, ET, PMF according to WHO classification)

排除标准

  • Pregnancy
  • Lack of informed consent
  • Age < 18 years
  • Cognitive dysfunctions

结局指标

主要结局

Prevalence of pulmonary hypertension at initial presentation and first echo

时间窗: Initial recruitment

次要结局

  • Mortality(1 and 5 years)
  • Incidence of pulmonary hypertension while under follow-up(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mette Brabrand

Staff Specialist

Odense University Hospital

研究点 (1)

Loading locations...

相似试验